Therapy Areas: Oncology
ConcertAI names new chief financial officer
11 June 2024 -

ConcertAI, a US-based company that deals with oncology predictive and generative AI SaaS Solutions and Real-World Data for healthcare and life sciences, announced on Monday that it has named Timothy (Tim) Albury as its new chief financial officer (CFO).

Albury, an accomplished finance executive, has served for 12 years at Arthur Andersen and around 25 years as CFO of various companies across multiple industry sectors. He has most recently served as CFO of AQuity Solutions. He was also a part of the leadership team growing KBI BioPharma, Osmotica Pharma, and Liquidia Corp (LQDA).

Albury said, 'ConcertAI is uniquely poised to expand its position as the clinical AI and Real-World Data leader. I am excited to join the talented ConcertAI team as the company enters a new phase of growth by bringing predictive and generative AI SaaS innovations to our customers in healthcare and clinical development.'